With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Genetically Modified, Cord Blood Derived Natural Killer Cell Therapy for High Grade Pediatric Brain Tumors||Children's Research Institute / Conrad Russell Cruz, MD, PhD||'A' Award Grants||2015||District of Columbia|
|Targeting the LIN28 Pathway in ATRT||The Johns Hopkins University School of Medicine / Eric Raabe, MD, PhD||'A' Award Grants||2015||Maryland|
|Inside-Out Immunotherapy: Combating Neuroblastoma via Nanoparticle-Directed Reprogramming of the Tumor Microenvironment||Vanderbilt University Medical Center / John Wilson, PhD||'A' Award Grants||2015||Tennessee|
|Adoptive Immunotherapy of Tr1 Cells to Improve Outcome of Allo-HSCT Treatment for Pediatric AML||Stanford University / Maria-Grazia Roncarolo, MD & Rosa Bachetta, MD||Reach Grants||2015||California|
|Targeting PI3Kdelta in Childhood Acute Lymphoblastic Leukemia||Children's Hospital Los Angeles / Yong-mi Kim, MD & Nora Heisterkamp, PhD||Reach Grants||2015||California|
|Therapeutic Reactivation of p53 to Overcome Apoptotic Resistance in Pediatric Leukemia||Dana-Farber Cancer Institute / Loren Walensky, MD, PhD & Kimberly Stegmaier, MD||Reach Grants||2015||Massachusetts|
|Targeting Novel Pediatric-Specific FLT3 Mutations||Fred Hutchinson Cancer Research Center / Soheil Meshinchi, MD,PhD||Reach Grants||2015||Washington|
|Molecular Annotation for Treatment of Childhood Cancers Trial: Neuroblastoma (MATCH-NB)||Children's Hospital of Philadelphia / Yael Mosse,M.D.||Bio-Therapeutic Impact Award||2015||Pennsylvania|
|Next-Generation Personalized Neuroblastoma Therapy (Nepenthe)||Children's Hospital of Philadelphia / Yael Mosse, MD & John Maris, MD||Bio-Therapeutic Impact Award||2015||Pennsylvania|
|Factors Affecting Parental Satisfaction, Anxiety and Comprehension of the Informed Consent in Pediatric Oncology Clinical Trials||University of California, San Diego / Paula Aristizabal, MD||Psychosocial Grants||2015||California|